Analytical Data
-
基因名
PDLIM3
- Application
-
别名
Actinin-associated LIM protein;Alpha-actinin-2-associated LIM protein
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q53GG5
-
表达区间
1-189aa
-
分子量
36.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PDLIM3, a member of the PDZ-LIM domain protein family, has garnered significant attention in recent years due to its roles in various cellular processes, including cytoskeletal organization, gene expression regulation, and cell signaling. This protein is characterized by its PDZ and LIM domains, which facilitate protein-protein interactions critical for cellular function. Research has shown that PDLIM3 is involved in the regulation of muscle development and differentiation, as well as influencing the behavior of various cell types in response to external stimuli. Moreover, aberrant expression of PDLIM3 has been implicated in several pathological conditions, including cancer and cardiovascular diseases, underscoring its potential as a biomarker and therapeutic target. The study of PDLIM3 recombinant protein is essential for elucidating its mechanisms of action and exploring its interactions with other cellular proteins. By producing and characterizing PDLIM3 in a recombinant form, researchers aim to gain insights into its structural properties and functional implications, paving the way for potential applications in disease treatment and biomarker development. Overall, the exploration of PDLIM3 through recombinant protein studies holds promise for advancing our understanding of its biological significance and therapeutic potential.
